Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, and breast cancer risk: observational and Mendelian randomization analyses with ∼430 000 women is a research paper published in Annals of Oncology (2020). On theSindex it has a DataRank of 0. It has been cited 166 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Cancer Research UK
Grant: C18281/A19169
Cancer Research UK
Grant: C8221/A19170
Wellcome Trust
Grant: LEAP 205212/Z/16/Z
National Institutes of Health
Grant: X01HG007492
National Institutes of Health
Grant: U19 CA148065
European Commission
Grant: H2020 633784
European Commission
Grant: HEALTH-F2-2009-223175
European Commission
Grant: 634935
Breast Cancer Risk after Diagnostic Gene Sequencing (BRIDGES)
Ministère de l'Ãconomie, de la Science et de l'Innovation - Québec
Grant: PSR-SIIRI-701
Cancer Research UK
Grant: C1287/A10710
Cancer Research UK
Grant: C1287/A10118
Cancer Research UK
Grant: C1287/A16563
Medical Research Council
Grant: MC_PC_17228
Cancer Research UK
Grant: 19169
Medical Research Council
Grant: MC_QA137853
Cancer Research UK
Grant: C8221/A1917
Wellcome Trust
Grant: 205212/Z/16/Z
World Health Organization
Grant: 001
European Commission
Grant: 223175
Collaborative Oncological Gene-environment Study
European Commission
Grant: 633784
Breast CAncer STratification: understanding the determinants of risk and prognosis of molecular subtypes
Wellcome Trust
Grant: 205212
Future of Animal-sourced Foods (FOAF)
National Institutes of Health
Grant: 5U19CA148065-04
Discovery Expansion and Replication
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institute for Health Research (NIHR)
Canadian Institutes of Health Research
Genome Canada
Government of Canada
NIHR Bristol Biomedical Research Centre
Wellcome Trust
Wellcome Trust
FWCI
14.62
Citation Percentile
1.0%
Influential Citations
4
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Body fatness and breast cancer risk in relation to phosphorylated mTOR expression in a sample of predominately Black women
Additional file 1 of Body fatness and breast cancer risk in relation to phosphorylated mTOR expression in a sample of predominately Black women
Additional file 1 of Dairy consumption and risks of total and site-specific cancers in Chinese adults: an 11-year prospective study of 0.5 million people
Additional file 1 of Dairy consumption and risks of total and site-specific cancers in Chinese adults: an 11-year prospective study of 0.5 million people
Additional file 1 of Birthweight, childhood body size, and timing of puberty and risks of breast cancer by menopausal status and tumor receptor subtypes
Additional file 1 of Birthweight, childhood body size, and timing of puberty and risks of breast cancer by menopausal status and tumor receptor subtypes
Additional file 1 of Identifying and ranking causal biochemical biomarkers for breast cancer: a Mendelian randomisation study
Additional file 1 of Identifying and ranking causal biochemical biomarkers for breast cancer: a Mendelian randomisation study
Additional file 2 of Identifying and ranking causal biochemical biomarkers for breast cancer: a Mendelian randomisation study
Additional file 2 of Identifying and ranking causal biochemical biomarkers for breast cancer: a Mendelian randomisation study
Additional file 1 of Association between human blood metabolome and the risk of breast cancer
Additional file 1 of Association between human blood metabolome and the risk of breast cancer
Additional file 1 of Genetically mimicked effects of ASGR1 inhibitors on all-cause mortality and health outcomes: a drug-target Mendelian randomization study and a phenome-wide association study
Additional file 1 of Genetically mimicked effects of ASGR1 inhibitors on all-cause mortality and health outcomes: a drug-target Mendelian randomization study and a phenome-wide association study
Additional file 4 of The impact of lipidome on breast cancer: a Mendelian randomization study
Additional file 5 of The impact of lipidome on breast cancer: a Mendelian randomization study
Additional file 4 of The impact of lipidome on breast cancer: a Mendelian randomization study
Additional file 5 of The impact of lipidome on breast cancer: a Mendelian randomization study
Additional file 1 of The impact of lipidome on breast cancer: a Mendelian randomization study
Additional file 2 of The impact of lipidome on breast cancer: a Mendelian randomization study